+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Myeloproliferative Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Myeloproliferative Neoplasms - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Plasmacytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Plasmacytoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Pipeline Insight, 2025 - Product Thumbnail Image

Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Radiologic Cancer Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Radiologic Cancer Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Squamous Cell Carcinoma Of The Lung - Pipeline Insight, 2025 - Product Thumbnail Image

Squamous Cell Carcinoma Of The Lung - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
T-cell Malignancies - Pipeline Insight, 2025 - Product Thumbnail Image

T-cell Malignancies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Untreated Metastatic Or Unresectable Melanoma- Pipeline Insight, 2025 - Product Thumbnail Image

Untreated Metastatic Or Unresectable Melanoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
IPSC Derived NK Cells- Pipeline Insight, 2025 - Product Thumbnail Image

IPSC Derived NK Cells- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ependymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Cutaneous Squamous Cell Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HER2-mutant Non-Small Cell Lung Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2-mutant Non-Small Cell Lung Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
CDK12 Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

CDK12 Inhibitor- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more